Depression affects nearly 10% of Americans at some point in their lives, yet the digital therapeutics (DTx) industry had long overlooked developing a dedicated...
Severe depression remains one of the most difficult mental health conditions to treat, especially when conventional medications and therapies fall short. For decades, electroconvulsive...
Pharmaceutical leader Otsuka (OTCMKTS: OTSKY) is partnering with Alphabet’s life sciences subsidiary Verily to launch an innovative longitudinal depression study aimed at advancing our...